https://www.cegat.de/web/wp-content/uploads/2018/12/Publikations-Keyvisual-V3.jpg10801920Sevvalli Thavapalanhttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim-300x77.pngSevvalli Thavapalan2019-01-10 11:19:132019-01-16 09:33:53De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies.
https://www.cegat.de/web/wp-content/uploads/2018/03/Publikation-Keyvisual-V2-blank-WEB.jpg5791030Sevvalli Thavapalanhttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim-300x77.pngSevvalli Thavapalan2019-01-02 10:07:402019-01-02 10:59:36Glycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?
CeGaT receives California CLIA State License and Accreditation – expanding diagnostic services in California. CeGaT GmbH is a CLIA certified laboratory for high complexity testing (CLIA# 99D2130225) approved by US authorities (Centers of Medicare & Medicaid Services- Clinical Laboratory Improvement Amendment Survey and Certificate Group) qualifying CeGaT to operate in 49 states or districts in […]
https://www.cegat.de/web/wp-content/uploads/2016/02/cegat_labor2.jpg4301500woltershttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim-300x77.pngwolters2018-12-21 13:43:102018-12-21 13:44:34CeGaT receives California CLIA State License and Accreditation
A significant increase in sensitivity leads to almost perfect coverage of all genes. Also new scientific findings have been incorporated. The Panel for Neuromuscular Diseases is now available in version seven. The sensitivity of the new version has been increased from > 98.4 % to > 99.997 % in non-homologous regions. This results in almost […]
https://www.cegat.de/web/wp-content/uploads/2018/02/Slider-NMD4-crop.jpg5601920woltershttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim-300x77.pngwolters2018-12-20 15:48:592018-12-20 15:48:59Update of the Panel for Neuromuscular Diseases
De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies.
/in Publications /by Sevvalli ThavapalanGlycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?
/in Publications /by Sevvalli ThavapalanCeGaT receives California CLIA State License and Accreditation
/in About CeGaT /by woltersCeGaT receives California CLIA State License and Accreditation – expanding diagnostic services in California. CeGaT GmbH is a CLIA certified laboratory for high complexity testing (CLIA# 99D2130225) approved by US authorities (Centers of Medicare & Medicaid Services- Clinical Laboratory Improvement Amendment Survey and Certificate Group) qualifying CeGaT to operate in 49 states or districts in […]
Update of the Panel for Neuromuscular Diseases
/in Diagnostic Panels /by woltersA significant increase in sensitivity leads to almost perfect coverage of all genes. Also new scientific findings have been incorporated. The Panel for Neuromuscular Diseases is now available in version seven. The sensitivity of the new version has been increased from > 98.4 % to > 99.997 % in non-homologous regions. This results in almost […]
GRIN2A-related disorders: genotype and functional consequence predict phenotype.
/in Publications /by Sevvalli Thavapalan